Cleared Traditional

K022093 - CHASE CARDIOVASCULAR PATCH KIT

K022093 is an FDA 510(k) clearance for CHASE CARDIOVASCULAR PATCH KIT, manufactured by Chase Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DXZ cleared through the Traditional 510(k) pathway after a 85-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2002
Decision
85d
Days
Class 2
Risk

K022093 is an FDA 510(k) clearance for the CHASE CARDIOVASCULAR PATCH KIT. Classified as Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene (product code DXZ), Class II - Special Controls.

Submitted by Chase Medical, Inc. (Richardson, US). The FDA issued a Cleared decision on September 20, 2002 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3470 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K022093

510(k) Number K022093 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 27, 2002
Decision Date September 20, 2002
Days to Decision 85 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 125d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXZ Device Classification - Class 2, Special Controls

Product Code DXZ Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3470
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXZ Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene

All 89
Devices cleared under the same product code (DXZ) and FDA review panel - the closest regulatory comparables to K022093.
CORRESTORE PATCH SYSTEM
K040162 · Somanetics Corp. · Mar 2004
PERIPATCH SHEET, MODELS 1.5P8, 4P4, 4P6, 6P8, 10P16, 1.5P16
K031948 · Pm Devices, Inc. · Sep 2003
CORRESTORE PATCH SYSTEM
K031586 · Somanetics Corp. · Aug 2003
CHARE CARIOVASCULAR PATCH
K021129 · Chase Medical, Inc. · Jun 2002
CHASE CARDIOVASCULAR PATCH KIT
K020233 · Chase Medical, Inc. · Mar 2002
CHASE CARDIOVASCULAR PATCH KIT
K020132 · Chase Medical, Inc. · Feb 2002